Linda Harrison
Overview
    Explore the profile of Linda Harrison including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              28
            
            
              Citations
              431
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Ghanem M, Srivastava R, Ektefaie Y, Hoppes D, Rosenfeld G, Yaniv Z, et al.
  
  
    medRxiv
    . 2024 Sep;
    
    PMID: 39228708
  
  
          One Sentence Summary: The percent of lung involved in disease improves prediction of unfavorable outcomes in pulmonary tuberculosis when added to clinical characteristics.
      
2.
        
    
    Morrow A, Orr N, Nash K, Coates H, Cross C, Evans J, et al.
  
  
    Children (Basel)
    . 2023 Jan;
          10(1).
    
    PMID: 36670715
  
  
          Health and well-being are holistic concepts that are perceived to be inseparable for Aboriginal and Torres Strait Islander peoples. We examined relationships between parent-reported ear symptoms for 787 Indigenous children...
      
3.
        
    
    Knych H, Weiner D, Harrison L, McKemie D
  
  
    BMC Vet Res
    . 2022 Dec;
          18(1):436.
    
    PMID: 36514067
  
  
          Background: Intra-articular corticosteroids, such as isoflupredone acetate, are commonly used in the treatment of joint inflammation, especially in performance horses. Following administration in a non-inflamed joints blood concentrations of isoflupredone...
      
4.
        
    
    Liegeon G, Harrison L, Nechba A, Halue G, Banchongkit S, Nilmanat A, et al.
  
  
    J Infect
    . 2019 Aug;
          79(5):454-461.
    
    PMID: 31401085
  
  
          Objectives: The risk of kidney dysfunction on the WHO recommended first line regimens containing tenofovir disoproxil fumarate (TDF) without protease inhibitors (PI) remains unclear in Asian patients, especially those with...
      
5.
        
    
    Salvadori N, Fan B, Teeyasoontranon W, Ngo-Giang-Huong N, Phanomcheong S, Luvira A, et al.
  
  
    Clin Infect Dis
    . 2019 Mar;
          69(1):144-146.
    
    PMID: 30924492
  
  
          In a randomized, double-blind, placebo-controlled trial of tenofovir disoproxil fumarate (TDF) use from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child transmission of hepatitis B virus, there...
      
6.
        
    
    Cressey T, Harrison L, Achalapong J, Kanjanavikai P, Patamasingh Na Ayudhaya O, Liampongsabuddhi P, et al.
  
  
    Antimicrob Agents Chemother
    . 2018 Oct;
          62(12).
    
    PMID: 30275094
  
  
          We assessed tenofovir exposure during pregnancy and postpartum in hepatitis B virus (HBV)-infected HIV-uninfected women receiving tenofovir disoproxil fumarate (TDF) to prevent mother-to-child transmission of HBV. Data from 154 women...
      
7.
        
    
    Jourdain G, Ngo-Giang-Huong N, Harrison L
  
  
    N Engl J Med
    . 2018 Jun;
          378(24):2350.
    
    PMID: 29897855
  
  
          No abstract available.
      
8.
        
    
    Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al.
  
  
    N Engl J Med
    . 2018 Mar;
          378(10):911-923.
    
    PMID: 29514030
  
  
          Background: Pregnant women with an elevated viral load of hepatitis B virus (HBV) have a risk of transmitting infection to their infants, despite the infants' receiving hepatitis B immune globulin....
      
9.
        
    
    George V, Harrison L, Roach M, Li X, Tierney C, Fischl M, et al.
  
  
    J Infect Dis
    . 2017 Oct;
          216(9):1159-1163.
    
    PMID: 29040604
  
  
          A nested case-cohort study was performed in participants of a clinical trial of first-line human immunodeficiency virus treatments to investigate plasma biomarkers of inflammation and microbial translocation for their association...
      
10.
        
    
    Melvin A, Warshaw M, Compagnucci A, Saidi Y, Harrison L, Turkova A, et al.
  
  
    J Pediatric Infect Dis Soc
    . 2017 Sep;
          6(3):e109-e115.
    
    PMID: 28903520
  
  
          Background: Data on long-term toxicity of antiretroviral therapy (ART) in HIV-infected children are sparse. PENPACT-1 was an open-label trial in which HIV-infected children were assigned randomly to receive protease inhibitor...